Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
14NOV

Moa raises £22.2m to outrun resistance

3 min read
18:53UTC

Moa Technology, an Oxford Plant Sciences spinout, closed a £22.2m Series C on 23 July after screening more than 900,000 compounds for herbicides that weeds have not yet defeated.

TechnologyDeveloping
Key takeaway

New herbicide chemistry from Oxford reaches farmers through four incumbent agrochemical companies, not through Moa.

Moa Technology, an Oxford Plant Sciences spinout from 2017, closed a £22.2 million Series C on Thursday 23 July co-led by Oxford Science Enterprises and Supernova Invest⁠1. The company has screened more than 900,000 compounds and found over 80 novel herbicide modes of action. Magdalen College Oxford joined the round alongside GrainInnovate, the Agri Investment Fund and Infinity Investment Partners⁠2.

A mode of action is the biochemical route by which a chemical kills a plant. Commercial herbicides have leaned on a handful of those routes for decades, weeds have evolved around them, and growers in Australia and the American Midwest are running short of chemistry that still works. Finding a genuinely new route is rare enough that agrochemical majors have gone years without one.

Moa Technology has built no sales force to carry those 80 routes to a field. Its research partnerships run through four incumbent agrochemical companies that already own the distribution and the regulatory Teams: Nufarm, Gowan, Certis Belchim and Corteva Agriscience. Moa's chemistry therefore reaches a field on somebody else's sales ledger. Commercialisation is routed through industry here as it is at Humanoid, though this buys a path to market rather than a factory, and none of it is equity.

University spinout deals fell 33% by count last year. A 2017 vintage closing a Series C with Parkwalk and Oxford University Innovation still on the register is what the surviving tail of that pipeline looks like. Agricultural chemistry runs on decade-long timelines: regulatory approval for a new active ingredient takes years after the science is settled, which is why the survivors are old and the count is falling.

Deep Analysis

In plain English

Moa Technology is a company that grew out of Oxford University's plant science department. Weeds on farms are increasingly resistant to the herbicides farmers already use, in the same way bacteria can become resistant to antibiotics. Moa built software that tests hundreds of thousands of chemical compounds to find new ways to kill resistant weeds that current products cannot. It raised £22.2m to keep developing these, and several big agricultural chemical companies are already working with it to test the most promising candidates.

Deep Analysis
Root Causes

Herbicide resistance evolves because repeated use of the same mode of action selects for the small fraction of a weed population that already carries a resistance mutation; with only a handful of commercial modes of action in wide global use, farmers have had no rotation option broad enough to break that selection pressure, which is the specific gap over 80 new modes of action would need to fill rather than merely adding another product using an existing mechanism.

Discovery of new modes of action stalled industry-wide because large agrochemical companies scaled back internal discovery chemistry after patent cliffs on glyphosate and other blockbusters reduced R&D budgets in the 2000s and 2010s, leaving a gap that a machine-learning screening specialist like Moa, spun out of Oxford Plant Sciences, could enter with lower fixed costs than an incumbent rebuilding a wet-lab discovery programme from scratch.

What could happen next?
  • Opportunity

    A confirmed new mode of action would give UK and global farmers their first genuinely new resistance-management tool in decades, extending the useful life of existing herbicides by allowing rotation.

  • Risk

    None of the 80-plus modes of action Moa reports finding in screening has yet been confirmed in field trials or regulatory filings, so the commercial number that matters, how many reach an approved product, remains unknown.

First Reported In

Update #13 · Humanoid hit $1.35bn on a customer order

PR Newswire· 31 Jul 2026
Read original →
Causes and effects
This Event
Moa raises £22.2m to outrun resistance
Moa has found new chemistry but built no sales force, so its route to a field runs through four incumbent agrochemical companies that already own the distribution.
Different Perspectives
Association of Investment Companies (Richard Stone)
Association of Investment Companies (Richard Stone)
The trust industry body criticised the Budget for leaving Venture Capital Trust relief at 20%. It had lobbied for the 30% rate to return.
Tax Justice UK
Tax Justice UK
The campaign group opposed the 10% founders' rate as a giveaway to a small group of wealthy owners. It said the BADR cut should have gone further, to abolition.
techUK
techUK
The trade body set the new relief against the BADR cut, which halves the most a seller can save to £30,000. It says the Budget takes back with BADR part of what it gives founders.
Startup Coalition
Startup Coalition
The founder lobby group welcomed the Budget package for startups. It treats the new relief as the strongest government support for founders in years.
HM Treasury
HM Treasury
The Treasury created a 10% founders' relief on up to £10m of lifetime gains and expects about 600 people a year to use it. It says the relief rewards founders behind the UK's fastest-growing companies.
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.